Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2021

Feb 11, 2021

29745_dirs_2021-02-10_d0bdd700-ea27-46db-803f-6f0b653ec9e7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2021-02-08

Reporting Person: Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-08 Common Stock A 9594 $205.77 Acquired 34616 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-08 Restricted Stock Unit $ A 4014 Acquired 2022-02-01 Common Stock (4014.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 927 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.